{ "id": "1a34dd45-e447-44ae-b129-2adecc7cc0be", "results": [ { "date": "2026-07-31", "last_updated": "2026-08-01", "snippet": "", "title": "CDRH New - News and Updates", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-29", "last_updated": "2026-08-01", "snippet": "|--|--|--|--|\n|Product Description|Recall Class|FDA Recall Posting Date|Recalling Firm|\n|Min

Medtronic initiated a voluntary Class I recall for specific lots of the HeartWare HVAD system due to potential pump stop issues caused by internal electrical faults.

{ "id": "80615837-85c8-4a71-995c-3bb70e701eac", "results": [ { "date": "2026-07-31", "last_updated": "2026-08-01", "snippet": "", "title": "CDRH New - News and Updates", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "The FDA lists the most serious type of medical device recalls, as well as early alert communic

ResMed initiated a correction for its Astral Ventilator, classified as a medical device recall by the FDA on July 31, 2026.

{ "id": "7299f142-1764-4ad1-8722-d69632935ef2", "results": [ { "date": "2026-07-31", "last_updated": "2026-08-01", "snippet": "", "title": "CDRH New", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "The FDA lists the most serious type of medical device recalls, as well as early alert communications about correc

Results from the 'HEART-FLOW' observational study showed a 22% reduction in unnecessary invasive coronary angiographies using non-invasive FFRct technology.

FDA cleared the Viz Reprocessing software, an AI-powered platform designed to enhance clinical workflow for neurovascular and cardiovascular image analysis.

{ "id": "c32457a5-e76e-4ac2-a53b-6f7c2511b7be", "results": [ { "date": "2026-07-31", "last_updated": "2026-08-01", "snippet": "", "title": "CDRH New", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "The FDA lists the most serious type of medical device recalls, as well as early alert communications about correc

The FDA confirmed a recall action for the ResMed Astral ventilator due to a reported correction issue, with notice posted on July 31, 2026.

search_response='1. Caristo Diagnostics\' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA\nURL: https://www.prnewswire.co.uk/news-releases/caristo-diagnostics-cari-heart-coronary-inflammation-technology-authorized-by-us-fda-302837667.html\nDate: 2026-07-29T14:00:00.000Z\nHighlights: OXFORD, England and STAMFORD, Conn., July 29, 2026 /PRNewswire/ -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, today announced that the U.S. Food and Drug A

{ "id": "9da96620-6a8e-48d4-962b-a8d2f61ab717", "results": [ { "date": "2026-07-31", "last_updated": "2026-07-29", "snippet": "", "title": "CDRH New - News and Updates", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-31", "last_updated": "2026-07-31", "snippet": "The FDA lists the most serious type of medical device recalls, as well as early alert communic

On July 27, 2026, the FDA granted 510(k) clearance to SurGenTec's ION-L Lumbar Facet Fixation System, enabling compatibility with Medtronic's StealthStation platform.

On July 19, 2026, Medtronic completed the acquisition of SPR Therapeutics for $650 million, enhancing its neuromodulation portfolio with non-opioid pain treatment devices.

On July 15, 2026, Medtronic initiated a recall of its Harmony Catheter Delivery System (DCS) due to a risk of the catheter tip detaching during procedures.

On July 10, 2026, the FDA approved Sanofi's Sarclisa Escena, a wearable injector form of the blood cancer drug Sarclisa, offering multiple myeloma patients a less burdensome alternative to intravenous infusions.

On July 13, 2026, the FDA granted De Novo classification to Claria Medical's Claria System, the first integrated tissue containment and removal system authorized for minimally invasive hysterectomy procedures.

search_response='1. Navi\'s Neonav Secures $6.8M After FDA 510(k) for Pediatri... | Biotech Intelligence Brief\nURL: https://getbiobrief.com/story/navi-neonav-fda-clearance-6-8m-funding\nDate: 2026-07-29T05:12:11.000Z\nHighlights: Navi\'s Neonav Secures $6.8M After FDA 510(k) for Pediatri... | Biotech Intelligence Brief ... - Following FDA 510(k) clearance, Navi Medical Technologies raises $6.8M to advance its Neonav ECG-based catheter placement system for neonates, with clinical evaluations und

{ "id": "c25feec6-15ec-4366-a3c8-193131a15782", "results": [ { "date": "2026-07-30", "last_updated": "2026-07-29", "snippet": "", "title": "CDRH New - News and Updates", "url": "https://www.fda.gov/medical-devices/medical-devices-news-and-events/cdrh-new-news-and-updates" }, { "date": "2026-07-31", "last_updated": "2026-07-30", "snippet": "The FDA lists the most serious type of medical device recalls, as well as early alert communic

Recent high-priority corrective actions and recalls for medical devices identified by the FDA.

Overview of significant venture capital deployments in the medical device and health tech sectors during July 2026.

Cardinal Health entered into definitive agreements to acquire the Diabetes Health business of AdaptHealth and Strive Medical to expand its at-home solutions platform.

BTIG analyst report detailing significant increases in FDA premarket approval (PMA) timelines for high-risk medical devices during the first half of 2026.

On July 17, 2026, the FDA approved the first oral PCSK9 inhibitor for lowering LDL cholesterol in adults with high cholesterol.

On July 24, 2026, the FDA issued an early alert regarding a potential issue with Boston Scientific's percutaneous catheter, indicating ongoing information collection.